Demand for Automated Cell Therapy Processing Systems in USA

Demand for automated cell therapy processing systems in USA is forecasted to grow from USD 0.7 billion in 2026 to USD 2.9 billion by 2036, expanding at a CAGR of 15.4%. Stem cell therapy systems account for 57.9% share in 2026 within the type segment. Pre-commercial and research and development scale systems represent 74.0% share in the scale segment.